Standard Treatment group Clinical Trials
2 recruitingDrug
Phase 21Not Applicable1
Showing 1–2 of 2 trials
Recruiting
Phase 2
ctDNA-MRD Guided Escalation of Ivonescimab and Docetaxel in Advanced NSCLC With Long-Term Responses to First-line Immunotherapy (CR1STAL-Adaptive)
Non-small Cell Lung CancerImmune Checkpoint Inhibitors (ICIs)
Second Xiangya Hospital of Central South University70 enrolled20 locationsNCT06951646
Recruiting
Not Applicable
Safety and Efficacy of Adipose-Derived Regenerative Cells (ADRCs) for Improving Hand Dysfunction in Systemic Sclerosis
Systemic Sclerosis (SSc)Hand Dysfunction
Cytori Therapeutics48 enrolled2 locationsNCT07360808